GW Pharmaceuticals Plc (GWPH): Price and Financial Metrics
GET POWR RATINGS... FREE!
GWPH Stock Price Chart Interactive Chart >
GWPH Price/Volume Stats
| Current price | $218.96 | 52-week high | $219.57 |
| Prev. close | $219.28 | 52-week low | $87.07 |
| Day low | $218.60 | Volume | 1,464,900 |
| Day high | $219.54 | Avg. volume | 899,771 |
| 50-day MA | $216.81 | Dividend yield | N/A |
| 200-day MA | $147.25 | Market Cap | 6.86B |
GW Pharmaceuticals Plc (GWPH) Company Bio
GW Pharmaceuticals plc, a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. It operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The company was founded in 1998 and is based in Cambridge, the United Kingdom.
Latest GWPH News From Around the Web
Below are the latest news stories about Gw Pharmaceuticals Plc that investors may wish to consider to help them evaluate GWPH as an investment opportunity.
DraftKings May Be The Next GW PharmaceuticalsPhoto by Scott Olson/Getty Images News via Getty Images By K C Ma and Lucas Juery DraftKings (DKNG) is a leader in the fast-growing US sports betting and iGaming industry. Sports bettors are often “sticky” in terms of the platform they use. DKNG has the most preferred and practical online... |
New Strong Sell Stocks for May 6thOYST, CDAY, GWPH, HRTG, and NATI have been added to the Zacks Rank #5 (Strong Sell) List on May 6, 2021 |
Jazz Pharmaceuticals' Acquisition of GW Pharmaceuticals ClosesJazz Pharmaceuticals (NASDAQ: JAZZ) and GW Pharmaceuticals are now under the same corporate roof. The two companies announced Wednesday that Jazz's acquisition of GW has been completed. In the companies' joint press release, Jazz CEO Bruce Cozadd was quoted as saying that the closing "mark[s] a transformative milestone in creating an innovative, high-growth, global biopharma leader in neuroscience with a worldwide commercial and operational footprint." |
Jazz Pharma (JAZZ) Q1 Earnings Beat, Sales Miss, Stock DownJazz Pharmaceuticals (JAZZ) reports mixed first-quarter 2021 results as earnings beat estimates while sales miss the same. Shares down |
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plcJazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader in the science, development and commercialization of cannabinoid-based prescription medicines. |
GWPH Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 116.68% |
| 5-year | 77.45% |
| YTD | N/A |
| 2021 | 0.00% |
| 2020 | 10.38% |
| 2019 | 7.36% |
| 2018 | -26.23% |
| 2017 | 18.13% |
Loading social stream, please wait...